hide
Free keywords:
Abeta-oligomers spastin Tau missorting MARK/par-1 Alzheimer disease DENDRITIC SPINE MORPHOLOGY ALZHEIMERS-DISEASE TRANSGENIC MICE ENDOGENOUS TAU MOUSE MODEL PROTEIN-TAU NEURONS NEURODEGENERATION PLASTICITY NEUROTOXICITY
Abstract:
Mislocalization and aggregation of A beta and Tau combined with loss of synapses and microtubules (MTs) are hallmarks of Alzheimer disease. We exposed mature primary neurons to A beta oligomers and analysed changes in the Tau/MT system. MT breakdown occurs in dendrites invaded by Tau (Tau missorting) and is mediated by spastin, an MT-severing enzyme. Spastin is recruited by MT poly-glutamylation, induced by Tau missorting triggered translocalization of TTLL6 (Tubulin-Tyrosine-Ligase-Like-6) into dendrites. Consequences are spine loss and mitochondria and neurofilament mislocalization. Missorted Tau is not axonally derived, as shown by axonal retention of photo-convertible Dendra2-Tau, but newly synthesized. Recovery from A beta insult occurs after A beta oligomers lose their toxicity and requires the kinase MARK (Microtubule-Affinity-Regulating-Kinase). In neurons derived from Tau-knockout mice, MTs and synapses are resistant to A beta toxicity because TTLL6 mislocalization and MT polyglutamylation are prevented; hence no spastin recruitment and no MT breakdown occur, enabling faster recovery. Reintroduction of Tau re-establishes A beta-induced toxicity in TauKO neurons, which requires phosphorylation of Tau's KXGS motifs. Transgenic mice overexpressing Tau show TTLL6 translocalization into dendrites and decreased MT stability. The results provide a rationale for MT stabilization as a therapeutic approach.
